Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
50 participants
INTERVENTIONAL
2018-10-01
2020-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
APIOC Sphere and APIOC Astigmatism
NCT04806802
Clinical Validation of the Apollo Daily Disposable Soft Contact Lenses
NCT05035017
Corneal Oxygen Uptake With Apioc Contact Lenses
NCT04031118
Evaluation of Investigational Daily Disposable Multifocal Contact Lenses Produced With Different Manufacturing Processes in Myopes
NCT04889625
Multi-Centre Clinical Evaluation Of Two Daily Disposable Contact Lenses
NCT01707238
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
DEVICE_FEASIBILITY
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Apioc Lens
All subjects will wear the same, Apioc Contact Lens design.
Apioc Contact Lens Design
Novel soft contact lens design.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Apioc Contact Lens Design
Novel soft contact lens design.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. The subject must have ≤ 1.50 D of corneal astigmatism.
3. The subject should have clear, healthy corneas.
4. The subject should have a normal, healthy conjunctiva in both eyes.
5. The subject should be free of active ocular disease. Refractive error and presbyopia are permitted.
6. The subject must provide written informed consent.
7. The subject must appear willing and able to adhere to the instructions set forth in this protocol.
Exclusion Criteria
2. No pterygia or corneal scarring that would interfere with contact lens wear.
3. No pinguecula or other conjunctival thickness abnormalities are permitted that would interfere with contact lens wear.
4. The subject should not be using any ocular pharmaceutical treatments, including artificial tears in the two weeks prior to the examination.
18 Years
60 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Lentechs, LLC
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Heidi Wagner, OD, MS
Role: PRINCIPAL_INVESTIGATOR
Ohio State University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
The Ohio State University
Columbus, Ohio, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
LEN001
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.